title: Nature-inspired design of motif-specific antibody scaffolds.
abstract: Aberrant changes in post-translational modifications (PTMs) such as phosphate groups underlie a majority of human diseases. However, detection and quantification of PTMs for diagnostic or biomarker applications often require PTM-specific monoclonal antibodies (mAbs), which are challenging to generate using traditional antibody-selection methods. Here we outline a general strategy for producing synthetic, PTM-specific mAbs by engineering a motif-specific 'hot spot' into an antibody scaffold. Inspired by a natural phosphate-binding motif, we designed and selected mAb scaffolds with hot spots specific for phosphoserine, phosphothreonine or phosphotyrosine. Crystal structures of the phospho-specific mAbs revealed two distinct modes of phosphoresidue recognition. Our data suggest that each hot spot functions independently of the surrounding scaffold, as phage display antibody libraries using these scaffolds yielded >50 phospho- and target-specific mAbs against 70% of target peptides. Our motif-specific scaffold strategy may provide a general solution for rapid, robust development of anti-PTM mAbs for signaling, diagnostic and therapeutic applications.
authors: Department of Pharmaceutical Chemistry, University of California, San Francisco, California, USA.
authors: James T
authors: JT
authors: Koerber
authors: Nathan D
authors: ND
authors: Thomsen
authors: Brett T
authors: BT
authors: Hannigan
authors: William F
authors: WF
authors: Degrado
authors: James A
authors: JA
authors: Wells
mesh_terms: D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D045163:Antibodies, Phospho-Specific / Q000096:biosynthesis* / Q000737:chemistry; D000918:Antibody Specificity / Q000276:immunology*; D018360:Crystallography, X-Ray; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010748:Phosphopeptides / Q000737:chemistry / Q000276:immunology; D015202:Protein Engineering; D057127:Single-Chain Antibodies / Q000276:immunology
chemical_list: D045163:Antibodies, Phospho-Specific; D010748:Phosphopeptides; D057127:Single-Chain Antibodies
references: Science. 2009 Mar 20;323(5921):1610-4
references: 19299620
references: J Biol Chem. 2009 Jul 31;284(31):20791-5
references: 19473967
references: Cell. 2011 Mar 4;144(5):646-74
references: 21376230
references: Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
references: 20057044
references: Nat Biotechnol. 2001 Jan;19(1):75-8
references: 11135557
references: Science. 2005 Apr 22;308(5721):523-9
references: 15845847
references: J Mol Biol. 2012 Nov 23;424(1-2):88-103
references: 22985966
references: Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12130-5
references: 15302935
references: Nat Rev Mol Cell Biol. 2006 Jul;7(7):473-83
references: 16829979
references: J Mol Biol. 2008 May 2;378(3):622-33
references: 18384812
references: Methods Mol Biol. 2011;717:3-43
references: 21370022
references: Proc Natl Acad Sci U S A. 2013 May 21;110(21):8477-82
references: 23650375
references: Chem Phys Lipids. 1986 Jun-Jul;40(2-4):303-14
references: 3742674
references: Nat Biotechnol. 2001 Apr;19(4):375-8
references: 11283598
references: Nature. 1990 Dec 6;348(6301):552-4
references: 2247164
references: Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92
references: 3881765
references: Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
references: 21460441
references: J Mol Biol. 2011 Feb 18;406(2):228-56
references: 21035459
references: J Biol Chem. 2012 Dec 28;287(53):44425-34
references: 23148212
references: Immunol Lett. 2010 May 4;130(1-2):43-50
references: 20005895
references: Structure. 2001 Mar 7;9(3):R33-8
references: 11286893
references: J Mol Biol. 2002 Jan 11;315(2):171-82
references: 11779237
references: N Engl J Med. 2002 Mar 7;346(10):752-63
references: 11882732
references: Nat Biotechnol. 2003 Feb;21(2):163-70
references: 12536217
references: Methods Enzymol. 1997;276:307-26
references: 27754618
references: Proc Natl Acad Sci U S A. 1991 May 15;88(10):4363-6
references: 1903540
references: Proteomics. 2008 Nov;8(21):4433-43
references: 18846511
references: Biomol Concepts. 2010 Oct;1(3-4):271-283
references: 21436958
references: Sci Signal. 2012 Sep 25;5(243):ra68
references: 23012655
references: Proteomics. 2004 Jun;4(6):1551-61
references: 15174125
references: J Mol Biol. 2004 Apr 23;338(2):299-310
references: 15066433
references: J Mol Biol. 2001 May 18;308(5):883-93
references: 11352579
references: Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1537-42
references: 14752198
references: J Mol Biol. 1991 Dec 5;222(3):581-97
references: 1748994
references: Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41
references: 11517324
references: N Biotechnol. 2010 May 31;27(2):118-28
references: 19883803
references: Science. 2011 May 6;332(6030):687-96
references: 21551058
references: Cell Commun Signal. 2012 Nov 07;10(1):32
references: 23134684
references: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references: 15572765
references: Trends Biochem Sci. 2000 Dec;25(12):596-601
references: 11116185
references: Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
references: 20124702
references: Nat Biotechnol. 2000 Dec;18(12):1287-92
references: 11101809
references: Cancer Res. 1995 May 1;55(9):1946-55
references: 7728765
references: Oncogene. 2001 Aug 23;20(37):5186-94
references: 11526507
references: Science. 1995 Jan 20;267(5196):383-6
references: 7529940
references: Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18950-5
references: 20956322
references: Acta Crystallogr D Biol Crystallogr. 1999 May;55(Pt 5):988-93
references: 10216295
references: J Mol Biol. 1998 Jul 3;280(1):1-9
references: 9653027
references: Nat Biotechnol. 2004 Sep;22(9):1139-45
references: 15314609